Article info

Download PDFPDF

Protocol
Magnesium in chronic haemodialysis (MAGIC-HD): a study protocol for a randomised controlled trial to determine feasibility and safety of using increased dialysate magnesium concentrations to increase plasma magnesium concentrations in people treated with haemodialysis

Authors

  • Nicoline H J Leenders Department of Nephrology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsDepartment of Physiology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • Caroline E. Douma Department of Nephrology, Spaarne Gasthuis, Hoofddorp, The Netherlands PubMed articlesGoogle scholar articles
  • Joost G.J. Hoenderop Department of Physiology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • Marc G. Vervloet Department of Nephrology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Nicoline H J Leenders; n.leenders{at}amsterdamumc.nl
View Full Text

Citation

Leenders NHJ, Douma CE, Hoenderop JG, et al
Magnesium in chronic haemodialysis (MAGIC-HD): a study protocol for a randomised controlled trial to determine feasibility and safety of using increased dialysate magnesium concentrations to increase plasma magnesium concentrations in people treated with haemodialysis

Publication history

  • Received April 4, 2022
  • Accepted October 3, 2022
  • First published November 21, 2022.
Online issue publication 
December 29, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.